3.5 %The pooled HIV-1 primary drug-resistance prevalence for all sites outside Uganda was 3.5% between 2007 and 2009.
OugandaVIH/sidaobserved 2007 and 2009published 2011The Lancet. Infectious diseaseseurope_pmcdocument of 13 observations
Gold tier: mechanically validated evidence, with its primary source.
473 evidence items · page 8 / 19
3.5 %The pooled HIV-1 primary drug-resistance prevalence for all sites outside Uganda was 3.5% between 2007 and 2009.
OugandaVIH/sidaobserved 2007 and 2009published 2011The Lancet. Infectious diseaseseurope_pmcdocument of 13 observations
5 local_casesAs of July 4, 2026, there were 5 local cases of Bundibugyo Virus Disease in Uganda.
Ougandamaladie à virus Bundibugyoobserved July 4, 2026Africa CDCdocument of 40 observations
11 recoveriesAs of 5 June 2026, there were 11 cumulative recoveries from Bundibugyo Virus Disease in the Democratic Republic of the Congo and Uganda.
Ouganda · RDCmaladie à virus Bundibugyoobserved 5 June 2026Africa CDCdocument of 15 observations
0.22 hazard_ratioIn post-hoc analysis of a randomized double-blind placebo-controlled trial, occurrence of stroke or death was lower in the zinc treatment arm among Ugandan children aged 1.00–4.99 years with sickle cell anemia, with an adjusted hazard ratio of 0.22 (95% CI, 0.05–1.00; p=0.05).
Ougandadrépanocytosepublished 2023Blood advanceseurope_pmcdocument of 4 observations
51 casesAs of 29 September 2024, Uganda reported a cumulative total of 51 confirmed mpox cases across 11 districts.
Ougandampoxobserved 29 September 2024Africa CDCdocument of 147 observations
13 health zonesThirteen health zones were affected by Bundibugyo Virus Disease across the Democratic Republic of the Congo and Uganda.
Ouganda · RDCmaladie à virus Bundibugyoobserved 23 May 2026Africa CDCdocument of 35 observations
0 casesThere were 0 new suspected cases of Bundibugyo Virus Disease in Uganda as of 22 May 2026.
Ougandamaladie à virus Bundibugyoobserved 22 May 2026Africa CDCdocument of 45 observations
Burundi, Central African Republic, Congo, Democratic Republic of the Congo, Gabon, Kenya, Rwanda, and Uganda reported mpox cases belonging to Clade I.
Burundi · Gabon · Kenya · Ouganda · RDC · RwandaClade I · mpoxAfrica CDCdocument of 11 observations
2 odds_ratioForced sexual initiation was significantly associated with recent experiences of emotional violence (OR = 2.0, 95% CI = 1.3–2.9) among youth in Nigeria, Uganda, and Zambia.
Nigeria · Ouganda · Zambieemotional violenceobserved 2014 and 2015published 2019Child abuse & neglectPubMeddocument of 8 observations
34 casesAs of 5 June 2026, there were 34 cumulative health care worker cases of Bundibugyo Virus Disease in the Democratic Republic of the Congo and Uganda.
Ouganda · RDCmaladie à virus Bundibugyoobserved 5 June 2026Africa CDCdocument of 15 observations
10 %As of 14 July 2026, Uganda reported 2 cumulative deaths from Bundibugyo Virus Disease (BDVD), corresponding to a case fatality rate (CFR) of 10%.
Ougandamaladie à virus Bundibugyoobserved 14 July 2026Africa CDCdocument of 89 observations
4 provincesFour provinces were affected by Bundibugyo Virus Disease across DRC and Uganda.
Ouganda · RDCmaladie à virus Bundibugyoobserved 07 June 2026Africa CDCdocument of 28 observations
8 recoveriesAs of 3 June 2026, there were 8 total cumulative recoveries from Bundibugyo Virus Disease across DRC and Uganda.
Ouganda · RDCmaladie à virus Bundibugyoobserved 3 June 2026Africa CDCdocument of 33 observations
44 %In Uganda, 44% of severe hypoxaemic cases were referred.
OugandahypoxaemiaHAL · Unilimdocument of 229 observations
1.8 %The K103N mutation was present in 1.8% of HIV-1 sequences between 2007 and 2009.
OugandaVIH/sidaobserved 2007 and 2009published 2011The Lancet. Infectious diseaseseurope_pmcdocument of 13 observations
50 per_cubic_millimeterESAT-6/CFP-10-induced interferon-γ responses were often negative for patients with CD4 T-cell counts <50 per cubic millimeters.
OugandaVIH/sidapublished 2016Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations
9,980 dosesUganda launched mpox vaccination on 1 February 2025 and had administered 9,980 out of 10,000 available doses as of 10 February 2025.
Ougandampoxobserved 10 February 2025Africa CDCdocument of 72 observations
15.5 %Intermediate prevalence levels of Plasmodium–Schistosoma co-infection were found in Uganda (15.5%), Tanzania (15.5%), Senegal (9.2%), Kenya (8.2%), and Ivory Coast (8.1%).
OugandapaludismeHAL · Unilimdocument of 74 observations
1.66 aPRAmong participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024, adjusted prevalence ratio for SARS-CoV-2 infection was 1.66 among those who received at least one dose of a COVID-19 vaccine compared to those who received no doses.
Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations
0.89 %As of 14 July 2026, Uganda had tested 2,242 samples for Bundibugyo Virus Disease (BDVD), with a positivity rate of 0.89%.
Ougandamaladie à virus Bundibugyoobserved 14 July 2026Africa CDCdocument of 89 observations
407 recoveriesAs of 15 July 2026, there were 407 total recoveries from Bundibugyo Virus Disease in the Democratic Republic of the Congo and Uganda combined.
Ouganda · RDCmaladie à virus Bundibugyoobserved 15 July 2026Africa CDCdocument of 103 observations
30 health zones/districtsThe Bundibugyo Virus Disease outbreak affected 30 health zones or districts across the Democratic Republic of the Congo and Uganda as of June 12, 2026.
Ouganda · RDCmaladie à virus Bundibugyoobserved 12 June 2026Africa CDCdocument of 18 observations
1 health zones or districtsThere was 1 health zone or district affected by Bundibugyo Virus Disease in Uganda as of 31 May 2026.
Ougandamaladie à virus Bundibugyoobserved 31 May 2026Africa CDCdocument of 34 observations
Five countries — DRC, Rwanda, Uganda, Central African Republic, and Nigeria — are currently vaccinating against mpox.
Nigeria · Ouganda · RDC · RwandampoxAfrica CDCdocument of 72 observations
1.5 odds_ratioForced sexual initiation was significantly associated with moderate/serious mental distress (OR = 1.5, 95% CI = 1.1–2.0) among youth in Nigeria, Uganda, and Zambia.
Nigeria · Ouganda · Zambiemoderate/serious mental distressobserved 2014 and 2015published 2019Child abuse & neglectPubMeddocument of 8 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.